Visual outcomes and clinical characteristic of patients with Dysthyroid Optic Neuropathy treated at Siriraj hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20201028004

Enrollment

120

Registered

2020-10-28

Start date

2020-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysthyroid Optic Neuropathy Dysthyroid Optic Neuropathy Graves Ophthalmopathy Thyroid Eye Disease Orbital Decompression Systemic steroid Visual Outcome

Interventions

120 patients diagnosed with dysthyroid optic neuropathy who received high&#45

dose systemic steroid or underwent orbital decompressive surgery

Treatment

Patients diagnosed with dysthyroid optic neuropathy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with dysthyroid optic neuropathy

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with other visual impairment including cataract(more than grade 2), glaucoma, high myopia, and corneal ulcer

Design outcomes

Primary

Measure	Time frame
Visual Acuity at 6 months after end of the treatment LogMAR score / ETDRS Visual Acuity Chart	—

Secondary

Measure	Time frame
Visual Field at 6 months after end of the treatment Humphrey or Goldmann Visual Field Test,Color Vision at 6 months after end of the treatment Ishihara test	—

Countries

Thailand

Contacts

Public ContactPimkwan Jaru-Ampornpan

Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University

pimkwan.j@gmail.com+66944199164

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026